Header cover image

Hong Kong (HSI) Healthcare Distributors Industry Analysis

UpdatedMay 10, 2024
DataAggregated Company Financials
Companies17
  • 7D3.0%
  • 3M2.6%
  • 1Y-20.4%
  • YTDn/a

The Healthcare Distributors industry is up 3.0% in the last week, with Sinopharm Group up 6.8%. In the same time, IVD Medical Holding was down 17%. However, the industry is down 20% over the past year. Looking forward, earnings are forecast to grow by 7.0% annually.

Industry Valuation and Performance

Has the Hong Kong Healthcare Distributors Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Fri, 10 May 2024HK$137.7bHK$769.6bHK$11.0b10.8x12.5x0.2x
Sun, 07 Apr 2024HK$129.8bHK$766.8bHK$11.1b10.9x11.7x0.2x
Tue, 05 Mar 2024HK$141.0bHK$761.1bHK$9.7b10.1x14.5x0.2x
Thu, 01 Feb 2024HK$130.9bHK$771.5bHK$9.8b10x13.3x0.2x
Sat, 30 Dec 2023HK$134.4bHK$771.3bHK$9.8b10.3x13.7x0.2x
Mon, 27 Nov 2023HK$141.9bHK$763.6bHK$9.6b11.5x14.7x0.2x
Wed, 25 Oct 2023HK$156.9bHK$748.8bHK$9.5b11.7x16.4x0.2x
Fri, 22 Sep 2023HK$168.2bHK$749.6bHK$9.5b12.2x17.6x0.2x
Sun, 20 Aug 2023HK$173.7bHK$729.2bHK$7.9b10.1x22.1x0.2x
Tue, 18 Jul 2023HK$164.8bHK$735.3bHK$9.4b9x17.5x0.2x
Thu, 15 Jun 2023HK$157.4bHK$704.6bHK$11.0b10.4x14.3x0.2x
Sat, 13 May 2023HK$161.3bHK$726.6bHK$11.4b11.2x14.1x0.2x
Mon, 10 Apr 2023HK$159.0bHK$733.1bHK$12.1b11.1x13.1x0.2x
Wed, 08 Mar 2023HK$143.7bHK$714.2bHK$13.1b11x11x0.2x
Fri, 03 Feb 2023HK$129.9bHK$735.9bHK$13.4b13.6x9.7x0.2x
Sun, 01 Jan 2023HK$126.3bHK$714.0bHK$13.0b13.3x9.7x0.2x
Tue, 29 Nov 2022HK$112.4bHK$687.6bHK$12.5b12.7x9x0.2x
Thu, 27 Oct 2022HK$58.3bHK$591.5bHK$8.1b12.9x7.2x0.1x
Sat, 24 Sep 2022HK$60.2bHK$607.4bHK$7.9b14.5x7.6x0.1x
Mon, 22 Aug 2022HK$63.9bHK$624.0bHK$8.5b13.8x7.5x0.1x
Wed, 20 Jul 2022HK$70.5bHK$629.8bHK$8.6b16.8x8.2x0.1x
Fri, 17 Jun 2022HK$68.9bHK$633.8bHK$8.7b16.2x7.9x0.1x
Sun, 15 May 2022HK$69.4bHK$618.5bHK$8.4b15.8x8.3x0.1x
Tue, 12 Apr 2022HK$69.0bHK$658.7bHK$9.0b15.6x7.7x0.1x
Thu, 10 Mar 2022HK$69.4bHK$648.3bHK$9.2b14.7x7.5x0.1x
Sat, 05 Feb 2022HK$70.2bHK$641.7bHK$8.9b15.2x7.9x0.1x
Mon, 03 Jan 2022HK$66.0bHK$642.9bHK$9.0b17.8x7.4x0.1x
Wed, 01 Dec 2021HK$65.0bHK$639.5bHK$8.9b13.8x7.3x0.1x
Fri, 29 Oct 2021HK$68.4bHK$637.2bHK$8.9b13x7.7x0.1x
Sun, 26 Sep 2021HK$73.1bHK$620.4bHK$8.8b15x8.3x0.1x
Tue, 24 Aug 2021HK$71.6bHK$619.7bHK$8.8b15.8x8.1x0.1x
Wed, 30 Jun 2021HK$83.1bHK$619.7bHK$8.8b14.2x9.4x0.1x
Price to Earnings Ratio

11.3x


Total Market Cap: HK$92.7bTotal Earnings: HK$8.2bTotal Revenue: HK$584.1bTotal Market Cap vs Earnings and Revenue0%0%0%
Hong Kong Healthcare Distributors Industry Price to Earnings3Y Average 11x202220232024
Current Industry PE
  • Investors are optimistic on the Hong Kong Healthcare Distributors industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 12.5x which is higher than its 3-year average PE of 11.0x.
  • The industry is trading close to its 3-year average PS ratio of 0.16x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Distributors industry have grown 10% per year over the last three years.
  • Revenues for these companies have grown 9.6% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Hong Kong Healthcare Distributors compare with similar industries?

HK Market2.53%
Healthcare0.90%
Healthcare Services0.78%
Healthcare Distributors3.03%
Managed Healthcare0%
Healthcare Facilities-0.81%
Healthcare Services-2.77%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
1099 Sinopharm GroupHK$21.509.6%
+HK$5.9b
-19.3%PE7x
874 Guangzhou Baiyunshan Pharmaceutical HoldingsHK$22.806.8%
+HK$2.4b
-12.6%PE8.3x
9955 ClouDr GroupHK$3.433.0%
+HK$58.7m
-63.3%PS0.5x
2289 Charmacy PharmaceuticalHK$13.883.6%
+HK$51.8m
73.5%PE27x
1345 Shanghai Pioneer HoldingHK$1.882.2%
+HK$47.0m
-30.1%PE14x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

1931

HK$1.59

IVD Medical Holding

7D

-25.7%

1Y

0%

1345

HK$1.88

Shanghai Pioneer Holding

7D

2.2%

1Y

-30.1%

874

HK$22.80

Guangzhou Baiyunshan Pharmaceutical Holdings

7D

6.8%

1Y

-12.6%

1099

HK$21.50

Sinopharm Group

7D

9.6%

1Y

-19.3%

6833

HK$0.23

Sinco Pharmaceuticals Holdings

7D

-5.0%

1Y

-43.0%

9885

HK$8.29

YSB

7D

-2.4%

1Y

n/a

401

HK$0.078

Wanjia Group Holdings

7D

39.3%

1Y

-56.7%

673

HK$0.92

China Health Group

7D

8.2%

1Y

-14.8%